Open Menu
Home
2020 Program
2020 Agenda
2020 Faculty
2020 Award Nominations
Registration Open
2020 Sponsors
2019 Program
2019 Agenda
Home
2020 Program
2020 Agenda
2020 Faculty
2020 Award Nominations
Registration Open
2020 Sponsors
2019 Program
2019 Agenda
|
Faculty
Meet Our Speakers
Linda Bosserman, MD, FACP, FASCO
Assistant Clinical Professor
City of Hope
Duarte, California
Julie Brahmer, MD, MSc
Professor
Johns Hopkins Medicine
Baltimore, Maryland
Lori Burt
Executive Director, Talent and Acquisition
City of Hope
Duarte, California
Caitlin Costello, MD
Associate Clinical Professor of Medicine
UC San Diego Health
La Jolla, California
Patricia Doykos, PHD
Lead, Health Equity Initiative and Director, BMS Foundation
Bristol Myers Squibb
New York, New York
Narjust Duma, MD
Assistant Professor - Thoracic Oncology
University of Wisconsin
Madison, Wisconsin
Kristen Hege, MD
Senior Vice President, Early Clinical Development, Oncology/Hematollogy and Cell Therapy
Bristol Myers Squibb
San Francisco, California
Bruna Pellini Ferreira, MD
Assistant Professor in the Division of Thoracic Oncology
H. Lee Moffitt Cancer Center
Tampa, Florida
Nicole Gormley, MD
Division Director (Acting)
U.S. Food and Drug Administration
Washington, DC
Julie Gralow, MD
Director, Breast Medical Oncolog
Seattle Cancer Care Alliance
Seattle, Washington
Anne Katz, PhD, RN FAAN
CNS and Sexuality Counselor
CancerCare Manitoba
Winnipeg, Canada
Alicia Morgans, MD, MPH
Associate Professor
Northwestern University - Feinberg School of Medicine
Chicago, IL
Phuong Morrow, MD, FACP
Vice President and Global Therapeutic Area Head of Hematology (Clinical Development)
Amgen
Thousand Oaks, California
Jarushka Naidoo, MBBCH, MHS
Assistant Professor of Oncology
Johns Hopkins Medicine University
Baltimore, Maryland
Beaumont Hospital Dublin
Dublin, Ireland
Debra Patt, MD, MPH, MBA
Medical Oncologist/Hematologist
US Oncology Network
Tatiana Prowell, MD
Associate Professor of Oncology and Breast Cancer Scientific Liaison
Johns Hopkins Medicine
Baltimore, Maryland
U.S. Food & Drug Administration
Dara Richardson, MD
Chief Patient Officer
Pfizer, Inc.
New York, New York
Bianca Santomasso, MD, PhD
Neuro-Oncologist & Neurologist
Memorial Sloan Kettering Cancer Center
New York, New York
Rachna Shroff, MD, MS
Chief, GI Medical Oncology
The University of Arizona Cancer Center
Tucson, Arizona
Lynn Schuchter, MD
Chief, Division of Hematology Oncology
Penn Medicine
Philadelphia, Pennsylvania
Cynthia Sears, MD
Program Leader, Microbiome Program
Professor of Medicine and oncology
Johns Hopkins Medicine
Baltimore, Maryland
Lecia Sequist, MD, MPH
Director, Center for Innovation in Early Cancer Detection
Massachusetts General Hospital
Boston, Masachusetts
Nina Shah, MD
Associate Professor
University of California San Francisco
San Francisco, California
Sonali Smith, MD, FASCO
Elmwood V. Jensen Professor of Medicine Interim Chief, Section of Hematology/Oncology
University of Chicago Medicine
Chicago, Illinois
Gary Teal, MBA
Vice President, Woodruff Health Sciences Center
Emory University
Atlanta, Georgia
Carrie Thompson, MD, MS
Associate Professor of Medicine
Mayo Clinic
Rochester, Minnesota
Julie M. Vose, MD, MBA
Chief, Hematology/Oncology Professor
University of Nebraska Medical Center
Eunice Wang, MD
Chief, Leukemia Service, Department of Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York
Shannon Westin, MD, MPH
Director, Early Drug Development and Phase I
The University of Texas
MD Anderson Cancer Center
Houston, Texas
CLOSE